New services for Indian medical device manufacturers announced

Published On 2016-11-29 06:28 GMT   |   Update On 2016-11-29 06:28 GMT

Benguluru : German testing and certification major TUV SUD has announced a range of services for medical device manufacturing sector in India, six months ahead of the crucial revision of European Union's (EU) Medical Device Regulations (MDR).


India accounts for 1.3 per cent of the global medical devices market which is worth $335 billion and backed by the 'Make in India' initiatives, the sector is estimated to grow to $ 8.6 billion by 2020, as per industry reports.


TUV SUD currently the world's largest EU notified body for all types of medical devices covered by EU directives and regulations announced a revised range of services that is set to give Indian exporters considerable lead time to realign their backend and be compliance ready as and when the new regulations come into play, the report said.


"We invite all the medical device manufacturers in India, to partner with us to improve their acceptability in global markets. Acceptance at a large scale, will help India be a formidable stakeholder in the global manufactural stage and contribute significantly towards the Make in India story," Suresh Kumar, Senior Vice President (Consumer Product Services) at TUV SUD South Asia, said in a statement.


As part of the newly announced set of services, TUV SUD will provide updated information in a timely manner through various communication modes such as webinars, whitepapers and information fact sheets.


Through knowledge sharing, TUV SUD will also enable medical device manufacturers to stay fully informed about the anticipated changes, and prepare to aid in achieving compliance with the new requirements.

Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News